We are live on ! Find out more

43 hedge funds and large institutions have $1.63M invested in cbdMD in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more call options, than puts

Call options by funds: $14K | Put options by funds: $3K

50% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 8

1.15% less ownership

Funds ownership: 13.03% → 11.87% (-1.2%)

7% less funds holding

Funds holding: 46 → 43 (-3)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

38% less capital inflows, than outflows

Capital inflows: $159K | Capital outflows: $256K

Holders
43
Holders Change
-3
Holders Change %
-6.52%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
12
Reduced
8
Closed
7
Calls
$14K
Puts
$3K
Net Calls
+$11K
Net Calls Change
-$10K

YCBD Hedge Fund Activity: Q4 2022 in Review

43 of the 6,244 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q4 2022, worth a combined $1.63M — down 7.9% from $1.77M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of YCBD and 5 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 12 added.

The largest buyer was Merlin Capital, adding an estimated $84.4K. The largest seller was Ameriprise, exiting entirely with an estimated $125K sold.

  • 43 institutional investors held cbdMD (YCBD) as of Q4 2022, down from 46 in Q3 2022.
  • Funds reported $1.63M of cbdMD stock for Q4 2022, down 7.9% quarter-over-quarter.
  • 5 funds opened new cbdMD positions in Q4 2022 and 7 closed out, a net change of -2 holders.
  • The largest cbdMD buyer in Q4 2022 was Merlin Capital, an estimated $84.4K added.
  • The largest cbdMD seller in Q4 2022 was Ameriprise, an estimated $125K sold.

Based on aggregated 13F filings for Q4 2022.